A class action against KPMG over the failure of six managed investment schemes for eucalyptus wood in Tasmania can’t add new claims against the accounting firm three months out from trial.
Novartis and and generic drug maker Pharmacor have resolved litigation over the Swiss pharmaceutical giant’s patents for blockbuster MS drug Gilenya.
The High Court will not wade into the global debate over whether artificial intelligence inventions should receive patent protection, letting stand a Full Court judgment that overturned a landmark victory for AI pioneer Dr Stephen Thaler.
A judge has ordered Smile Direct Club and its Australian unit to pay a $3.5 million penalty and reimburse customers for misleading them into believing they would be reimbursed by their insurers for the dental care company’s costly teeth straighteners.
The High Court has rejected a special leave application by underworld figure Mick Gatto seeking to revive defamation claims against the ABC over an article which he said accused him of threatening to kill gangland lawyer Nicola Gobbo.
Legislation introduced in the wake of massive cyberattacks against Optus and Medibank that will increase penalties for serious privacy law violations to $50 million has sailed through the House just two weeks after being introduced.
The former general manager of sales for Fiat Chrysler Australia has sued the car company for allegedly terminating him for taking two periods of leave after being diagnosed with an auto-immune condition.
Liberty Financial unit Minerva has challenged a judgment that found two schemes it carried out were done with the primary purpose of securing a tax advantage.
A second securities class action has been filed against failed Blue Sky Alternative Investments and auditor EY alleging financial reports materially overstated the health of the asset manager ahead of its collapse three years ago.
Media company The Economist has failed in its opposition to registration of a trade mark for The Beer Economist, with an IP Australia delegate saying the mark was not substantially identical or deceptively similar to the UK publisher’s brand.